This transcript has been edited for clarity.
Hi. I'm Art Caplan. I'm at the Division of Medical Ethics at the New York University Grossman School of Medicine.
Every once in a while at my school, I get referrals about interesting or difficult clinical cases where doctors would like some input or advice that they can consider in managing a patient. Sometimes those requests come from other hospitals to me. I've been doing that kind of ethics consulting, both as a member of various ethics committees and sometimes individually, when, for various reasons, doctors don't want to go to the Ethics Committee as a first stop.
There was a very interesting case recently involving a young woman I'm going to call Tinslee. She was 17 years old and she suffered, sadly, from recurrent metastatic osteogenic sarcoma. She had bone cancer. It had first been diagnosed at the age of 9. She had received chemotherapy and been under that treatment for a while.
If osteosarcomais treated before it spreads outside the area where it began, the 5-year survival rate for people like her is about 75%. If the cancer spreads outside of the bones and gets into surrounding tissues, organs, or — worse — into the lymph nodes and starts traveling around, the 5-year survival rate drops to about 60%.
COMMENTARY
A Teenage Girl Refuses More Cancer Treatment; Her Father Disagrees
Tough Decisions From My Ethics Caseload
Arthur L. Caplan, PhD
DisclosuresJuly 10, 2023
This transcript has been edited for clarity.
Hi. I'm Art Caplan. I'm at the Division of Medical Ethics at the New York University Grossman School of Medicine.
Every once in a while at my school, I get referrals about interesting or difficult clinical cases where doctors would like some input or advice that they can consider in managing a patient. Sometimes those requests come from other hospitals to me. I've been doing that kind of ethics consulting, both as a member of various ethics committees and sometimes individually, when, for various reasons, doctors don't want to go to the Ethics Committee as a first stop.
There was a very interesting case recently involving a young woman I'm going to call Tinslee. She was 17 years old and she suffered, sadly, from recurrent metastatic osteogenic sarcoma. She had bone cancer. It had first been diagnosed at the age of 9. She had received chemotherapy and been under that treatment for a while.
If osteosarcomais treated before it spreads outside the area where it began, the 5-year survival rate for people like her is about 75%. If the cancer spreads outside of the bones and gets into surrounding tissues, organs, or — worse — into the lymph nodes and starts traveling around, the 5-year survival rate drops to about 60%.
Medscape Business of Medicine © 2023 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: A Teenage Girl Refuses More Cancer Treatment; Her Father Disagrees - Medscape - Jul 10, 2023.
Tables
Authors and Disclosures
Authors and Disclosures
Author
Arthur L. Caplan, PhD
Director, Division of Medical Ethics, New York University Langone Medical Center, New York, NY
Disclosure: Arthur L. Caplan, PhD, has disclosed the following relevant financial relationships:
Served as a director, officer, partner, employee, advisor, consultant, or trustee for: Johnson & Johnson's Panel for Compassionate Drug Use (unpaid position)
Serves as a contributing author and advisor for: Medscape